People | April 06, 2026
Sanofi appoints Dr Parikshit Chaudhari as Head of Market Access & Pricing Strategy
He brings extensive cross-functional expertise built through leadership roles
He brings extensive cross-functional expertise built through leadership roles
They also differentiated the innovator biologic Semaglutide molecule from newer synthetic or chemical generic versions entering the market
Parliament clears reform bill replacing jail terms for procedural lapses with graded monetary penalties across key health laws
The company spotlights micronutrient’s role in immunity, skin and bone health through digital and radio outreach on National Vitamin C Day
Key FDA decisions and pivotal late-stage obesity and breast cancer data could reshape competitive positioning
DBT-BIRAC, BioE3 and the Rs 10,000-crore Biopharma SHAKTI scheme aim to accelerate innovation, biomanufacturing and exports
This marks a meaningful step in the company's continued expansion in the region
Certification by TÜV SÜD Product Service GmbH reinforces the company's commitment to globally benchmarked standards in safety, quality, and performance
The company has achieved a turnover of around Rs 100 crore in FY 2025–26 and aims to achieve a turnover of Rs 500 crore in next three years
Eylea 2mg (intravitreal aflibercept injection) is an anti-VEGF therapy that blocks a protein responsible for abnormal blood vessel growth and leakage in the retina
Subscribe To Our Newsletter & Stay Updated
